ES2179067T3 - Complejo inmunomodulador anti-sida. - Google Patents

Complejo inmunomodulador anti-sida.

Info

Publication number
ES2179067T3
ES2179067T3 ES94907595T ES94907595T ES2179067T3 ES 2179067 T3 ES2179067 T3 ES 2179067T3 ES 94907595 T ES94907595 T ES 94907595T ES 94907595 T ES94907595 T ES 94907595T ES 2179067 T3 ES2179067 T3 ES 2179067T3
Authority
ES
Spain
Prior art keywords
aids
medicinal product
allows
complex anti
immunomodulator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94907595T
Other languages
English (en)
Inventor
Fernand Torossian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2179067T3 publication Critical patent/ES2179067T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

COMPLEJO DE VACUNA TERAPEUTICO NO ESPECIFICO, QUE ACTUA POR INMUNOMODULACION, QUE PERMITE LA REGULACION DE LAS DEFENSAS NATURALES DEL ORGANISMO. ESTE MEDICAMENTO PERMITE, ENTRE OTRAS COSAS, LA NEGACION DE LOS ANTIGENES P24 DEL SIDA. SE COMPONE BASICAMENTE DE ARN, DE FRACCIONES SELECTIVAS DE MEMBRANAS DE GERMENES DE MICROBIOS, DE SECUENCIAS PARTICULARES DE AMINOACIDOS, DE CLORURO SODICO Y DE ANTIINFLAMATORIO DE ESTEROIDE, EN PROPORCIONES DETERMINADAS. ESTE MEDICAMENTO, SEGUN EL INVENTO, SE DESTINA PARTICULARMENTE AL TRATAMIENTO DE LAS ENFERMEDADES DE INMUNODEFICIENCIA ADQUIRIDA.
ES94907595T 1993-03-31 1994-02-18 Complejo inmunomodulador anti-sida. Expired - Lifetime ES2179067T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9303879A FR2703252B1 (fr) 1993-03-31 1993-03-31 Complexe immunomodulateur anti SIDA.

Publications (1)

Publication Number Publication Date
ES2179067T3 true ES2179067T3 (es) 2003-01-16

Family

ID=9445666

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94907595T Expired - Lifetime ES2179067T3 (es) 1993-03-31 1994-02-18 Complejo inmunomodulador anti-sida.

Country Status (14)

Country Link
US (1) US6503512B1 (es)
EP (1) EP0644773B1 (es)
JP (1) JPH08500846A (es)
CN (1) CN1106202C (es)
AT (1) ATE219680T1 (es)
AU (1) AU6110994A (es)
CA (1) CA2136870C (es)
DE (1) DE69430858T2 (es)
DK (1) DK0644773T3 (es)
ES (1) ES2179067T3 (es)
FR (1) FR2703252B1 (es)
MX (1) MXPA94002284A (es)
PT (1) PT644773E (es)
WO (1) WO1994022462A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008011884A1 (es) * 2006-07-27 2008-01-31 Ramirez Castro Angel Dr Nuevo inmunomodulador

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2745186B1 (fr) * 1996-02-26 1998-12-31 Torossian Fernand Narbey Complexe immunomodulateur et ses utilisations pour le traitement et la prevention des recidives des affections par helicobacter
NO311807B1 (no) * 1999-03-04 2002-01-28 Bionor Immuno As HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV
WO2008118118A1 (en) * 2007-03-27 2008-10-02 The United States Of America As Represented By The Secretary Of The Army, Walter Reed Army Institute Of Research Artificial invaplex
US8765706B2 (en) 2009-09-02 2014-07-01 Kyoto Prefectural Public University Corporation Composition comprising rna derived from lactic acid bacterium as effective component

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2253499B1 (es) * 1973-12-10 1977-11-04 Fabre Sa Pierre
FR2388563A1 (fr) * 1977-04-29 1978-11-24 Fabre Sa Pierre Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires
FR2444464A1 (fr) * 1978-12-19 1980-07-18 Fabre Sa Pierre Proteoglycanes bacteriens purifies, procede pour leur preparation et vaccin les contenant
FR2471785A1 (fr) * 1979-12-21 1981-06-26 Fabre Sa Pierre Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
DE102010029147B4 (de) * 2010-05-20 2012-04-12 Semikron Elektronik Gmbh & Co. Kg Verfahren zur Ermittlung der Temperatur eines Leistungshalbleiters

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008011884A1 (es) * 2006-07-27 2008-01-31 Ramirez Castro Angel Dr Nuevo inmunomodulador

Also Published As

Publication number Publication date
DE69430858T2 (de) 2003-02-13
DK0644773T3 (da) 2002-10-07
AU6110994A (en) 1994-10-24
EP0644773B1 (fr) 2002-06-26
MXPA94002284A (es) 2005-04-01
WO1994022462A1 (fr) 1994-10-13
US6503512B1 (en) 2003-01-07
EP0644773A1 (fr) 1995-03-29
FR2703252A1 (fr) 1994-10-07
CN1106980A (zh) 1995-08-16
CA2136870A1 (fr) 1994-10-13
PT644773E (pt) 2002-11-29
DE69430858D1 (de) 2002-08-01
CN1106202C (zh) 2003-04-23
FR2703252B1 (fr) 1996-09-06
CA2136870C (fr) 2008-11-04
ATE219680T1 (de) 2002-07-15
JPH08500846A (ja) 1996-01-30

Similar Documents

Publication Publication Date Title
ES2179193T3 (es) Combinaciones sinergicas de zidovudina, 1592u89 y 3tc.
ES2151906T3 (es) Utilizacion de envolventes de bacterias del orden de las beggiatoales o del genero vitreoscilla como ingrediente activo de un medicamento destinado a estimular la inmunidad no especifica.
ES2057124T3 (es) Producto terapeutico para el tratamiento de estados peri- o post-menopausicos.
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
AU8335291A (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals
ES2133138T3 (es) Nucleosidos terapeuticos.
BR9406893A (pt) Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids
AR024074A1 (es) FRAGMENTO ABETA UNIDO A UN PÉPTIDO PORTADOR PARA PREVENIR O TRATAR ENFERMEDADES ASOCIADAS CON DEPoSITOS AMILOIDES DE ABETA, COMPOSICIONES FARMACÉUTICAS QUE LO CONTIENEN, Y SU USO EN LA PREPARACION DE MEDICAMENTOS.
EA200000608A1 (ru) Предотвращение и лечение амилоидогенного заболевания
BR0107972A (pt) Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano
FI20001231A7 (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
DE59003895D1 (de) Arbeitszange.
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
NL970039I2 (nl) Prostaglandinederivaten voor de behandeling van glaucoma of oculaire hypertensie.
ES2040106T3 (es) Utilizacion de la acetil d-carnitina en el tratamiento terapeutico del glaucoma.
MX9204454A (es) Derivados de tiourea para inhibir la replicacion del virus de inmunodeficiencia humana y formulado farmaceutico que los contiene.
EP0626177A3 (en) Food for people infected with HIV.
ES2177796T3 (es) Extraccion por disolvente de polihidroxialcanoatos a partir de biomasafacilitada por el uso de un no disolvente marginal para pha.
BR0110486A (pt) Antranilamidas e sua aplicação como medicamento
RU94045825A (ru) Применение материала, полученного из mycobacterium vaccae для производства терапевтического средства для лечения психических заболеваний, способ лечения психических заболеваний, продукт, содержащий антигенный и/или иммунорегуляторный материал, фармацевтическое средство
ES2062100T3 (es) Empleo de acetil l-carnitina en el tratamiento terapeutico de cataratas y composiciones farmaceuticas utiles en este tratamiento.
ES2179067T3 (es) Complejo inmunomodulador anti-sida.
ES2176263T3 (es) 5,6-dihidropironas derivadas como inhibidores de proteasa y agentes antivirus.
DK0777669T3 (da) 4-[2-amino-6-(cyclopropylamino)-9H-purin-yl]-2-cyclopenten-1-methanolsuccinat som antiviralt middel